Document:

SECURITIES PURCHASE AGREEMENT

    

    

    This SECURITIES PURCHASE AGREEMENT (the “Agreement”), dated as of December 30, 2020, by and
      between Grow Capital, Inc., a Nevada corporation, with headquarters located at 2485 Village View Drive, Suite 180, Henderson, NV 89074 (the “Company”), and [*], a Company incorporated in the State of [*] / an individual
      residing at [*] (“Buyer”).

    

    

    WHEREAS:

    

    

    The Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration
      afforded by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “1933 Act”) and specifically including Section 4(a)(2), thereunder; and

    

    

    Buyer desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement, [*] (*)
      restricted shares of the Company’s common stock, $0.001 par value per share (“Common Stock”).

    

    

    NOW THEREFORE, the Company and
        the Buyer hereby agree as follows: 

     

          

     Purchase and Sale of Common Stock.

     

          

    Purchase of Common Stock. Buyer agrees to purchase from the Company and the Company agrees to sell and transfer to Buyer [*] (*) restricted shares of Common Stock (the “Securities”) for a purchase price of Twenty Five Cents
        [$0.25] per share for an aggregate Purchase Price of [*] Dollars (*).

    

    

    Form of Payment. On or before Closing,
        Buyer shall pay the Purchase Price by wire transfer of immediately available funds to the Company, in accordance with the Company’s written wiring instructions, or as otherwise authorized by the Company.

    

    

    Closing. The purchase and sale of the
        Securities shall take place within 10 days from the date of this Agreement (the “Closing”). At the Closing, Buyer shall deliver to the Company the Purchase Price and the Company shall deliver to Buyer one or more stock certificates representing the
        Securities (or a statement from the transfer agent reflecting such Securities in book entry format). At and at any time after the Closing, the parties shall duly execute, acknowledge and deliver all such further assignments, conveyances,
        instruments and documents, and shall take such other action consistent with the terms of this Agreement to carry out the transactions contemplated by this Agreement.

    

    

    Buyer’s Representations and Warranties. The Buyer represents
        and warrants to the Company that:

    

    

    Investment Purpose. As
        of the date hereof, the Buyer is purchasing the Common Stock for its own account and not with a present view towards the public sale or distribution thereof, except pursuant to sales registered or exempted from registration under the 1933 Act; provided, however, except as otherwise set forth in this Agreement, that by making the representations
        herein, the Buyer does not agree to hold any of the Securities for any minimum or other specific term and reserves the right to dispose of the Securities at any time in accordance with or pursuant to a registration statement or an exemption under
        the 1933 Act.

    
      1

      
        

    

    

    

    Accredited Investor Status. The Buyer is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D of the 1933 Act (an “Accredited Investor”).

    

    

    Reliance on Exemptions. The Buyer
        understands that the Securities are being offered and sold to it in reliance upon specific exemptions from the registration requirements of federal and state securities laws and that the Company is relying upon the truth and accuracy of, and the
        Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and understandings of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of the Buyer to acquire the
        Securities.

    

    

    Information. The Buyer has been
        furnished with all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of the Securities which have been requested by the Buyer. The Buyer has been afforded the opportunity to ask
        questions of, and to receive answers from, representatives of the Company. Neither such inquiries nor any other due diligence investigation conducted by Buyer or any of its advisors or representatives shall modify, amend or affect Buyer’s right to
        rely on the Company’s representations and warranties contained in Section 3 below. The Buyer understands that its investment in the Securities involves a significant degree of risk. The Buyer is not aware of any facts that may constitute a breach
        of any of the Company's representations and warranties made herein. The Buyer is aware the Company is not current in its periodic filings and so information normally available to the public through its SEC filings is not currently available. The
        Buyer has had the opportunity to ask questions of, and to receive answers from, representatives of the Company concerning any of this information.

    

    

    Governmental Review. The Buyer understands
        that no United States federal or state agency or any other government or governmental agency has passed upon or made any recommendation or endorsement of the Securities.

    

    

    Transfer or Re-sale. The Buyer
        understands that the sale or re-sale of the Securities has not been and is not being registered under the 1933 Act or any applicable state securities laws, and the Securities may not be transferred unless the Securities are sold pursuant to an
        effective registration statement under the 1933 Act, the Buyer shall have delivered to the Company, at the cost of the Buyer, an opinion of counsel that shall be in form, substance and scope customary for opinions of counsel in comparable
        transactions to the effect that the Securities to be sold or transferred may be sold or transferred pursuant to an exemption from such registration, which opinion shall be accepted by the Company, the Securities are sold or transferred to an
        “affiliate” (as defined in Rule 144 promulgated under the 1933 Act (or a successor rule) (“Rule 144”) of the Buyer who agrees to sell or otherwise transfer the Securities only in accordance with this Section 2(f) and who is an Accredited Investor,
        the Securities are sold pursuant to Rule 144, or the Securities are sold pursuant to Regulation S under the 1933 Act (or a successor rule) (“Regulation S”), and the Buyer shall have delivered to the Company, at the cost of the Buyer, an opinion of
        counsel that shall be in form, substance and scope customary for opinions of counsel in corporate transactions, which opinion shall be accepted by the Company; (ii) any sale of such Securities made in reliance on Rule 144 may be made only in
        accordance with the terms of said Rule and further, if said Rule is not applicable, any re-sale of such Securities under circumstances in which the seller (or the person through whom the sale is made) may be deemed to be an underwriter (as that
        term is defined in the 1933 Act) may require compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC thereunder; and (iii) neither the Company nor any other person is under any obligation to register such
        Securities under the 1933 Act or any state securities laws or to comply with the terms and conditions of any exemption thereunder (in each case).

    
      2

      
        

    

    

    

    Legends. The Buyer
        understands that the Securities will bear a restrictive legend in accordance with Section 2(f) above (and that stop-transfer orders may be placed against transfer of the certificates for such Securities).

    

    

    No Short-Sales. For a period of twenty-four (24) months from the date of this
        Agreement, Buyer will not, directly or through an affiliate, engage in any open market Short Sale (as defined below) of any shares of Company’s common stock. As used herein, “Short Sale” has the meaning provided in Rule 3b-3 under the Securities
        Exchange Act of 1934, as amended.

    

    

    Authorization; Enforcement. This
        Agreement has been duly and validly authorized. This Agreement has been duly executed and delivered on behalf of the Buyer, and this Agreement constitutes a valid and binding agreement of the Buyer enforceable in accordance with its terms.

    

    

    Confidentiality; Material Non-Public Information. The Buyer expressly acknowledges and agrees that certain of the Confidential
      Information disclosed to it, including, but not limited to, the information concerning this private placement, or the terms, conditions or other facts relating thereto or the fact that Confidential Information has been made available to the Buyer,
      includes material non-public information that has not been publicly disclosed by the Company. In addition, the Buyer expressly acknowledges and agrees that it is an “insider” of the Company, and may from time to time receive or be aware of certain
      Confidential Information that may represent material non-public information that has not been publicly disclosed by the Company. The Buyer understands that federal securities laws impose restrictions on trading based on information regarding this
      offering or any other material non-public information. The Buyer expressly agrees that until such time as the Confidential Information is disclosed to the public by the Company, the
      Recipient will hold in confidence and not disclose or make use of, or in any way disseminate within his own organization or to any third party, any Confidential Information of the Company which is supplied to or obtained by him. In addition, the
      Buyer agrees that he will (i) not use the Confidential Information in such a way as to violate the 1933 Act, the Securities Exchange Act of 1934, as amended (the “1934 Act”), and any other rules or regulations promulgated thereunder; (ii) communicate
      only with the designated representatives of the Company concerning the Confidential Information; (iii) keep all Confidential Information confidential and in his sole possession; and (iv) not engage in any trading activity involving any securities of
      the Company, including, but not limited to options, short sales, hedging or any other derivatives or positions concerning securities of the Company. 

    

    

    “Confidential Information’’ as used in this Agreement shall mean any and all documents, materials, data and/or
      information, in whatever form or format (including, without limitation, electronic media) which relates to the business of the Company or its affiliates provided or disclosed to the Buyer and that is either confidential, proprietary or otherwise not
      generally available to the public, whether or not marked confidential. Confidential Information includes, by way of example and without limitation, the Company’s confidential and/or proprietary information, any material non- public information
      (within the meaning of Regulation FD promulgated under the 1933 Act and the 1934 Act) and/or trade secrets that have been developed or used and/or will be developed and that cannot be obtained readily by third parties from outside sources; financial
      information; corporate information; business plans; budgets; valuations; financial projections; records; customer lists; business forecasts; information regarding the Company's internal operations; plans and strategies for development, expansion,
      divestitures or acquisitions, or any proposals, bids or letters of intent for such; executive summaries; business models; and business, sales and marketing plans of the

    

    

    

    

    
      3

      
        

    

    

    

    Company and its affiliates. Notwithstanding the foregoing, the term “Confidential Information” shall not include
      information which becomes or is generally available to the public other than as a result of a disclosure by or through Buyer, or that the Buyer is legally required to disclose; provided, however, that if the Buyer is requested or ordered to disclose
      any such information pursuant to any court or other government order or any other applicable legal procedure, it shall provide the Company with prompt notice of any such request or order in time sufficient to enable the Company to seek an appropriate
      protective order.

    

    

    Representations and Warranties of the Company. The Company represents and warrants to the Buyer that:

    

    

    Organization and Qualification. The
        Company and each of its subsidiaries, if any, is a corporation duly organized, validly existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate and other) to own, lease,
        use and operate its properties and to carry on its business as and where now owned, leased, used, operated and conducted.

    

    

    Authorization; Enforcement. (i) The
        Company has all requisite corporate power and authority to enter into and perform this Agreement and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance with the terms hereof and thereof, (ii)
        the execution and delivery of this Agreement by the Company and the consummation by it of the transactions contemplated hereby and thereby have been duly authorized by the Company’s Board of Directors and no further consent or authorization of the
        Company, its Board of Directors, or its shareholders is required, and (iii) this Agreement has been duly executed and delivered by the Company by its authorized representative, and such authorized representative is the true and official
        representative with authority to sign this Agreement and the other documents executed in connection herewith and bind the Company accordingly.

    

    

    Acknowledgment Regarding Buyer’ Purchase of Securities. The Company acknowledges and agrees that the Buyer is acting solely in the capacity of arm’s length purchasers with respect to this Agreement and the transactions contemplated hereby. The Company further acknowledges that
        the Buyer is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this Agreement and the transactions contemplated hereby and any statement made by the Buyer or any of its respective
        representatives or agents in connection with this Agreement and the transactions contemplated hereby is not advice or a recommendation and is merely incidental to the Buyer’ purchase of the Securities. The Company further represents to the Buyer
        that the Company’s decision to enter into this Agreement has been based solely on the independent evaluation of the Company and its representatives.

    

    

    No Integrated Offering. Neither the
        Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would require registration
        under the 1933 Act of the issuance of the Securities to the Buyer. The issuance of the Securities to the Buyer will not be integrated with any other issuance of the Company’s securities (past, current or future) for purposes of any shareholder
        approval provisions applicable to the Company or its securities.

    

    

    Bad Actor. No officer or director of the
        Company would be disqualified under Rule 506(d) of the Securities Act as amended on the basis of being a "bad actor" as that term is established in the September 19, 2013 Small Entity Compliance Guide published by the Securities and Exchange
        Commission.

    
      4

      
        

    

    

    

    Governing Law; Miscellaneous.

    

    

    Governing Law. This
        Agreement shall be governed by and construed in accordance with the laws of the State of Nevada without regard to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this
        Agreement shall be brought only in the state courts of Nevada or in the federal courts located in the state of Nevada. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted hereunder
        and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The prevailing party shall be entitled to recover from
        the other party its reasonable attorney's fees and costs.

    

    

    Counterparts; Signatures by Facsimile.
        This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute one and the same agreement and shall become effective when counterparts have been signed by each party and
        delivered to the other party. This Agreement, once executed by a party, may be delivered to the other party hereto by facsimile transmission of a copy of this Agreement bearing the signature of the party so delivering this Agreement.

    

    

    Headings. The headings of this Agreement
        are for convenience of reference only and shall not form part of, or affect the interpretation of, this Agreement.

    

    

    Severability. In the event that any
        provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform with such
        statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision hereof.

    

    

    Entire Agreement; Amendments. This
        Agreement and the instruments referenced herein contain the entire understanding of the parties with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company nor the Buyer makes
        any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may be waived or amended other than by an instrument in writing signed by the majority in interest of the Buyer.

    

    

    Notices. All notices,
        demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return
        receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, (iv) via electronic mail or (v) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address
        as such party shall have specified most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation
        generated by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal business hours where such notice is to be received) or delivery via electronic mail, or the first business day
        following such delivery (if delivered other than on a business day during normal business hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service, fully prepaid,
        addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for such communications shall be:

    

    

    

    

    
      5

      
        

    

    
      

      

      

      

      If to the Company, to:

      

      

      Grow Capital, Inc.

      2485 Village View Drive, Suite 180

      Henderson, NV 89074

      Email: info@growcapital.com 

       

      

      If to the Buyer:

               [*]

      

      

      Each party shall provide notice to the other party of any change in address.

      

      

      Successors and Assigns. This
          Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns. Neither the Company nor the Buyer shall assign this Agreement or any rights or obligations hereunder without the prior written consent of
          the other. Notwithstanding the foregoing, the Buyer may assign its rights hereunder to any person that purchases Securities in a private transaction from the Buyer or to any of its “affiliates,” as that term is defined under the 1934 Act, without
          the consent of the Company.

      

      

      Third Party Beneficiaries. This
          Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

      

      

      Further Assurances. Each party shall do
          and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out
          the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

      

      

      IN WITNESS WHEREOF, the undersigned Buyer and the Company have caused this Agreement to be duly executed as of the date first above written.

       

      

      
        	Seller

                	 	 	Buyer 

              	 
	Grow Capital, Inc.  

              	 	 	[*]	 
	 	 	 	 	 
	
                /s/

              	 	 	
                /s/

              	 
	Name: Carl Sanko 

              	 	 	
                Name

              	 
	
                Title: Secretary 

                

              	 	 	
                Title

              	 

      

      

      

      

                                                                

          

      

    

    
      6

      
        

    

     

      

    
      

      

      Payment of the Subscription Price should be sent via wire transfer to:

       

      

      Chase Bank

      Routing Number: 322271627

      Account Name: Grow Capital, Inc.

      Account Number: [*]Exhibit 4.2 

 

NEITHER THIS WARRANT NOR THE SHARES
OF COMMON STOCK UNDERLYING THIS WARRANT OF BLONDER TONGUE LABORATORIES, INC. (THE “COMPANY”) HAVE BEEN REGISTERED UNDER
THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR UNDER ANY STATE SECURITIES LAW AND MAY NOT BE PLEDGED, SOLD,
ASSIGNED OR TRANSFERRED UNTIL (i) A REGISTRATION STATEMENT WITH RESPECT THERETO IS EFFECTIVE UNDER THE ACT AND ANY APPLICABLE STATE
SECURITIES LAW AND SUCH SALE OR TRANSFER IS MADE IN ACCORDANCE WITH SUCH REGISTRATION STATEMENT AND ANY OTHER APPLICABLE STATE
SECURITIES LAW OR (ii) THE COMPANY RECEIVES A WRITTEN OPINION OF COUNSEL TO THE COMPANY OR OTHER COUNSEL TO THE HOLDER OF SUCH
WARRANT (OR SUCH UNDERLYING SHARES OF COMMON STOCK), PROVIDED SUCH OTHER COUNSEL IS REASONABLY SATISFACTORY TO THE COMPANY, THAT
SUCH PLEDGE, SALE, ASSIGNMENT OR TRANSFER MAY BE MADE WITHOUT AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR APPLICABLE STATE
SECURITIES LAWS. 

 

Date: May 6, 2020

 

WARRANT TO PURCHASE 22,273 SHARES OF
COMMON STOCK

OF

BLONDER
TONGUE LABORATORIES, INC.

 

THIS CERTIFIES that,
for value received, VFT Special Ventures, Ltd., a Pennsylvania limited partnership (the “Holder”), is entitled
to purchase from Blonder Tongue Laboratories, Inc., a Delaware corporation (the “Company”), Twenty-Two Thousand
Two-Hundred Seventy-Three (22,273) (“Warrant Shares”) fully paid, validly issued and non-assessable unregistered
shares of common stock of the Company, $.001 par value per share (the “Common Stock”), subject to adjustment
as provided herein, at a purchase price of $0.55 per share (“Exercise Price”).

 

1.       Vesting.
The purchase rights under this Warrant shall vest and be exercisable for all of the Warrant Shares upon the issuance of this Warrant
and until April 24, 2025 (the “Exercise Period”).

 

2.       Exercise
of Warrant. This Warrant may be exercised in whole or in part (but not as to fractional shares and only with respect to properly
vested purchase rights) during the Exercise Period by the surrender of the Warrant, with the Purchase Agreement attached hereto
as Rider A properly completed and duly executed, at the principal office of the Company at One Jake Brown Road, Old Bridge,
New Jersey 08857, or such other location which shall at that time be the principal office of the Company, and upon payment to the
Company of the Exercise Price multiplied by the number of shares to be purchased upon such exercise. The Exercise Price shall be
paid in immediately available funds to the order of the Company by cashier’s check, certified check or wire transfer. Upon
receipt thereof, the Company shall, as promptly as practicable, execute or cause to be executed and deliver to the Holder a certificate
or certificates as the Holder shall designate representing the number of shares represented by the Holder’s exercise or in
the alternative by the issuance of book-entry shares. Unless and until such time as the Warrant Shares have been registered under
the Securities Act of 1933, as amended (“Securities Act”), certificates representing such Warrant Shares shall
bear restrictive legends. The stock certificate or certificates so delivered shall be in such denominations as may be specified
in said notice and shall be registered in the name of the Holder or in such other name as shall be designated in such notice. This
Warrant shall be deemed to have been exercised and such certificate or certificates shall be deemed to have been issued and the
Holder or such other person so designated shall be deemed to have become a holder of record of such shares for all purposes, as
of the date said notice and payment in full is received by the Company. Unless this Warrant has expired, if this Warrant shall
have been exercised only in part, a new Warrant of like tenor and for such number of shares as the Holder shall direct, representing
in the aggregate the right to purchase a number of shares with respect to which this Warrant shall not have been exercised, shall
also be issued to the Holder within such time.

 

3.       Transfer/Warrant
Shares Legend. This Warrant and the rights hereunder shall be non-transferrable, except as permitted by and in compliance with
applicable law. Each certificate representing Warrant Shares shall contain a legend in substantially the following form:

 

THE SHARES OF STOCK
REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 OR APPLICABLE STATE OR OTHER SECURITIES
LAWS. UNLESS AN EXEMPTION IS AVAILABLE OR THE SHARES ARE REGISTERED UNDER SAID ACT AND LAWS, THE SHARES MUST BE HELD INDEFINITELY.

 

4.       Certain
Covenants of the Company. The Company covenants and agrees that all shares which may be issued upon the exercise of this Warrant,
will, upon issuance, be duly and validly issued, fully paid and nonassessable. The Company covenants and agrees that during the
Exercise Periods the Company will at all times have authorized, and reserved for the purpose of issue upon exercise of the purchase
rights evidenced by this Warrant, a sufficient number of shares of its Common Stock to provide for the exercise of the rights represented
by this Warrant.

 

5.       Anti-Dilution
Provisions. The number and character of the shares underlying this Warrant shall be subject to adjustment only as provided
in this Section 5. In the event of a stock split, stock dividend, reverse stock split or combination of the Common Stock of the
Company, an equitable adjustment shall be made by the Company in the number of shares for which this Warrant has been issued with
respect thereto, and the Exercise Price which must be paid therefor, provided that no such adjustment shall either (i) diminish
the proportionate interest of the Holder prior to the occurrence of the event or (ii) increase the aggregate Exercise Price to
be paid by the Holder upon exercise of the Warrant in full. In addition, in case at any time and from time to time during the Exercise
Periods, the Company shall be a party to any transaction, including, without limitation, a merger, consolidation, liquidation,
combination, reorganization or recapitalization of the Common Stock (each, a “Transaction”), in which the previously
outstanding common stock of the Company shall be changed into or exchanged for different securities of the Company or common stock
or other securities of another corporation (collectively, “Acquiror Common Stock”) or other property (including
cash) or any combination of the foregoing, then in such event: (i) the Warrant shall become fully exercisable notwithstanding the
date of the event and (ii) as often as such event shall occur, as a condition of the consummation of the Transaction, the Company
or the surviving company, as the case may be, shall make lawful and adequate provision so that the Holder, upon the exercise thereof
at any time on or after the consummation of the Transaction during the Exercise Periods, shall be entitled to receive, and the
Warrant shall thereafter represent the right to receive, in lieu of the common stock issuable upon such conversion prior to such
consummation (determined on a fully vested basis), the securities or other property to which the Holder would have been entitled
upon consummation of the Transaction if the Holder had exercised such Warrant immediately prior thereto. There shall be no preemptive
rights associated with the Warrant or the Warrant Shares issuable thereunder.

 

    1 

     

    

 

6.       Change
in Control. In the event of any contemplated transaction which may constitute a change in control of the Company, to the extent
applicable, the vesting of the Holder’s right to exercise the Warrant shall accelerate and all Holder rights that are not
then vested and exercisable pursuant to Section 1 above shall become vested and exercisable immediately upon the change in control
and shall be exercisable until the expiration of the Exercise Period. For this purpose, “change in control of the Company”
means a change in control of such nature that it would be required to be reported to the Securities and Exchange Commission (“SEC”)
pursuant to Schedule 14A of Regulation 14A or any successor provision under the Securities Exchange Act of 1934, as amended (the
“Exchange Act”) (whether or not the Company is then subject to such reporting requirements). A change of control
will be deemed to have occurred if any person, other than persons or entities who on the date hereof are the “beneficial
owners” (as determined pursuant to Sections 13(d) and 14(d) of the Exchange Act), directly or indirectly, of securities of
the Company representing 10% or more of the combined voting power of the Company’s then outstanding securities, is or becomes
the “beneficial owner” of 25% or more of the combined voting power of the outstanding securities of the Company or
if during two consecutive year periods, the directors at the beginning of such periods cease for any reason during the two-year
period to constitute a majority of the Board of Directors of the Company.

 

7.       Notice
of Adjustments. Whenever any of the number of shares of Common Stock purchasable or Exercise Price to be paid under the terms
of this Warrant shall be adjusted pursuant to Section 5 hereof, the Company shall notify the Holder at the Holder’s last
address known to the Company.

 

8.       Fractional
Shares. No fractional shares of the Company’s Common Stock will be issued in connection with any purchase hereunder but
in lieu of such fractional shares, the Company shall make a cash refund therefor equal in amount to the product of the applicable
fraction multiplied by the Exercise Price.

 

9.       Registration
Rights.

 

(a) Piggyback Rights.
If the Company proposes to register any of its Common Stock under the Securities Act in connection with the public offering of
such securities solely for cash (other than in (i) a registration
relating to the sale of securities to employees of the Company or a subsidiary pursuant to a stock option, stock purchase, or
similar plan; (ii) a registration relating to a transaction under Rule 145 promulgated by the SEC under the Securities Act; (iii)
a registration on any form that does not include substantially the same information as would be required to be included in a registration
statement covering the sale of the Registrable Securities (as defined below); (iv) a registration in connection with an offering
pursuant to which the Company is seeking to receive less than $2,500,000), the Company shall, at such time, promptly give
the Holder notice of such registration. Upon the request of Holder, given within twenty (20) days after such notice is given by
the Company, the Company shall, subject to the provisions of Subsection 9(b), cause to be registered (x) all of the Common
Stock issuable or issued upon exercise of this Warrant and (y) any Common Stock issued as (or issuable upon the conversion or
exercise of any warrant, right, or other security that is issued as) a dividend or other distribution with respect to, or in exchange
for or in replacement of, the shares referenced in clause (x) above (collectively, “Registrable Securities”)
that the Holder has requested to be included in such registration. The Company shall have the right to terminate or withdraw any
registration initiated by it under this Section 9 before the effective date of such registration, whether or not the Holder
has elected to include Registrable Securities in such registration. The expenses (other than Selling Expenses (as defined below))
of such withdrawn registration shall be borne by the Company in accordance with Subsection 9(d). 

 

(b)       Underwriting
Requirements. In connection with any offering involving an underwriting of shares of the Company’s capital stock pursuant
to Subsection 9(a), the Company shall not be required to include any of the Holder’s Registrable Securities in such
underwriting unless the Holder accepts the terms of the underwriting as agreed upon between the Company and its underwriters, and
then only in such quantity as the underwriters in their sole discretion determine will not jeopardize the success of the offering
by the Company. If the total number of securities, including Registrable Securities, requested by stockholders to be included in
such offering exceeds the number of securities to be sold (other than by the Company) that the underwriters in their reasonable
discretion determine is compatible with the success of the offering, then the Company shall be required to include in the offering
only that number of such securities, including Registrable Securities, which the underwriters and the Company in their sole discretion
determine will not jeopardize the success of the offering.

 

(c)       Furnish
Information. It shall be a condition precedent to the obligations of the Company to take any action pursuant to this Section
9 with respect to the Registrable Securities of the Holder that the Holder shall furnish to the Company such information regarding
itself, the Registrable Securities held by it, and the intended method of disposition of such securities as is reasonably required
to effect the registration of the Holder’s Registrable Securities.

 

(d)       Expenses
of Registration. All expenses (other than underwriting discounts, selling commissions, and stock transfer taxes applicable
to the sale of Registrable Securities, and fees and disbursements of counsel for any Holder (collectively, “Selling Expenses”))
incurred in connection with registrations, filings, or qualifications pursuant to Section 9, including all registration,
filing, and qualification fees; printers’ and accounting fees; fees and disbursements of counsel for the Company shall be
borne and paid by the Company.

 

(e)       Delay
of Registration. Holder shall not have any right to obtain or seek an injunction restraining or otherwise delaying any registration
pursuant to this Warrant as the result of any controversy that might arise with respect to the interpretation or implementation
of this Section 9.

 

    2 

     

    

 

(f)       Indemnification.
If any Registrable Securities are included in a registration statement under this Section 9:

 

(i) To the extent permitted
by law, the Holder will indemnify and hold harmless the Company, and each of its directors, each of its officers who has signed
the registration statement, each Person (if any), who controls the Company within the meaning of the Securities Act, legal counsel
and accountants for the Company, any underwriter (as defined in the Securities Act), and any controlling Person of any such underwriter,
against any Damages (defined below), in each case only to the extent that such Damages arise out of or are based upon actions or
omissions made in reliance upon and in conformity with written information furnished by or on behalf of the Holder expressly for
use in connection with such registration; and the Holder will pay to the Company and each other aforementioned Person any legal
or other expenses reasonably incurred thereby in connection with investigating or defending any claim or proceeding from which
Damages may result, as such expenses are incurred; provided, however, that the indemnity agreement contained in this Subsection
9(f) shall not apply to amounts paid in settlement of any such claim or proceeding if such settlement is effected without the
consent of the Holder, which consent shall not be unreasonably withheld. For purposes of this Section 9, “Damages”
means any loss, damage, claim or liability (joint or several) to which a party hereto may become subject under the Securities Act,
the Exchange Act, or other federal or state law, insofar as such loss, damage, claim or liability (or any action in respect thereof)
arises out of or is based upon (i) any untrue statement or alleged untrue statement of a material fact contained in any registration
statement of the Company, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements
thereto; (ii) an omission or alleged omission to state therein a material fact required to be stated therein, or necessary to make
the statements therein not misleading; or (iii) any violation or alleged violation by the
indemnifying party (or any of its agents or affiliates)
of the Securities Act, the Exchange Act, any state securities law, or any rule or regulation promulgated under the Securities Act,
the Exchange Act, or any state securities law.

 

(ii) Promptly after receipt
by an indemnified party under this Subsection 9(f) of notice of the commencement of any action (including any governmental
action) for which a party may be entitled to indemnification hereunder, such indemnified party will, if a claim in respect thereof
is to be made against any indemnifying party under this Subsection 9(f),
give the indemnifying party notice of the commencement thereof. The indemnifying party shall have the right to participate in such
action and to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified
party (together with all other indemnified parties that may be represented without conflict by one counsel) shall have the right
to retain one separate counsel, with the fees and expenses to be paid by the indemnifying party, if representation of such indemnified
party by the counsel retained by the indemnifying party would be inappropriate due to actual or potential differing interests between
such indemnified party and any other party represented by such counsel in such action. The failure to give notice to the indemnifying
party within a reasonable time of the commencement of any such action shall relieve such indemnifying party of any liability to
the indemnified party under this Subsection 9(f), to the extent that such
failure materially prejudices the indemnifying party’s ability to defend such action. The failure to give notice to the indemnifying
party will not relieve it of any liability that it may have to any indemnified party otherwise than under this Subsection 9(f).

 

(iii) Notwithstanding
the foregoing, to the extent that the provisions on indemnification and contribution contained in the underwriting agreement entered
into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting
agreement shall control.

 

(iv) Unless otherwise
superseded by an underwriting agreement entered into in connection with the underwritten public offering, the obligations of the
Company and the Holder under this Subsection 9(f) shall survive the completion of any offering of Registrable Securities
in a registration under this Section 9, and otherwise shall survive the termination of this Warrant.

 

(g)       Termination
of Registration Rights. The right of the Holder to request registration or inclusion of Registrable Securities in any registration
pursuant to Subsection 9(a) shall terminate upon such time as Rule 144 or another similar exemption under the Securities Act is
available for the sale of the Holder’s shares.

 

10.       Charges,
Taxes and Expenses. Issuance of certificates for Warrant Shares shall be made without charge to the Holder for any issue or
transfer tax or other incidental expense in respect of the issuance of such certificate, all of which taxes and expenses shall
be paid by the Company, and such certificates shall be issued in the name of the Holder or in such name or names as may be directed
by the Holder; provided, however, that in the event certificates for Warrant Shares are to be issued in a name other
than the name of the Holder, this Warrant when surrendered for exercise shall be accompanied by a form of assignment acceptable
to the Company duly executed by the Holder; and the Company may require, as a condition thereto, the payment of a sum sufficient
to reimburse it for any transfer tax incidental thereto.

 

    3 

     

    

  

11.       Investment
Representations. By accepting this Warrant, Holder represents and warrants to the Company that: (i) this Warrant is being acquired
by it for its own account for investment purposes only and (subject to the disposition of its property being at all times within
its control) not with a view to resale, distribution, or other disposition; (ii) any Warrant Shares which may be issued to Holder
upon exercise of this Warrant will be acquired by it for its own account for investment purposes only and (subject to the disposition
of its property being at all times within its control) not with a view to resale, distribution, or other disposition; (iii) Holder
is able to bear the economic risk of investment in this Warrant and the Warrant Shares, can afford to sustain a total loss on such
investment, and has such knowledge and experience in financial and business matters that it is capable of evaluating the merits
and risks of its proposed investment; (iv) when issued, and upon any exercise of the Warrant, Holder acknowledges that it is and
will be an “accredited investor” as such term is defined in Rule 501(a)(1), (2), (7) or (8) under the Securities Act;
(v) Holder understands that there is no public market for this Warrant, that there may never be a public market for this Warrant,
that in the future there may not be a public or liquid market for the Warrant Shares, and, therefore, that Holder may have to bear
the risk of its investment in this Warrant and any Warrant Shares indefinitely; and (vi) subject to Section 5.2 hereof, the Company
shall not be required to issue any of the Warrant Shares unless such issuance complies with the Securities Act and any applicable
state or other securities laws. Holder understands and acknowledges that the Company is relying upon the accuracy and truthfulness
of these representations and warranties to issue the Warrant and any Warrant Shares to Holder.

 

12.       Loss,
Theft, Destruction or Mutilation. Upon receipt by the Company of evidence reasonably satisfactory to it that this Warrant has
been mutilated, destroyed, lost or stolen, and in the case of any destroyed, lost or stolen Warrant, a bond of indemnity reasonably
satisfactory to the Company, or in the case of a mutilated Warrant, upon surrender and cancellation thereof, the Company will execute
and deliver in the Holder’s name, in exchange and substitution for the Warrant so mutilated, destroyed, lost or stolen, a
new Warrant of like tenor substantially in the form thereof with appropriate insertions and variations.

 

13.       No
Stockholder Rights. The Holder shall not by virtue hereof be entitled to any rights as a stockholder in the Company.

 

14.       Definition
of Person. For purposes of this Warrant, “Person” means an individual, corporation, partnership, limited
liability company, trust or other entity.

 

15.       Headings.
The descriptive headings of the several sections of this Warrant are inserted for convenience only and do not constitute a part
of this Warrant.

 

16.       Governing
Law. This Warrant shall be governed by the substantive laws of the State of Delaware, without regard to principles of conflicts
of law.

 

17.       Amendment.
This Warrant may be amended, waived or terminated only by an instrument in writing signed by the Company and the Holder.

 

18.       Severability.
Wherever possible, each provision of this Warrant shall be interpreted in such manner as to be effective and valid under applicable
law, but if any provision of this Warrant shall be prohibited by or invalid under applicable law, such provision shall be ineffective
to the extent of such prohibition or invalidity, without invalidating the remainder of such provisions or the remaining provisions
of this Warrant

 

19.       Acceptance.
Receipt of this Warrant by the Holder shall constitute acceptance of and agreement to the foregoing terms and conditions.

 

    4 

     

    

  

IN WITNESS WHEREOF, the Company
has caused this Warrant to be signed by its duly authorized officer on the date of this Warrant.

 

	 	BLONDER TONGUE LABORATORIES, INC.
	 	 
	 	By:	 
	 	 	Edward R. Grauch, Chief Executive Officer & President
	 	 	 
	 	 	 
	 	By:	 
	 	 	Eric Skolnik, Secretary

 

    5 

     

    

 

RIDER A

TO

WARRANT TO PURCHASE 22,273 SHARES OF
COMMON STOCK

OF

BLONDER TONGUE LABORATORIES, INC.

 

PURCHASE AGREEMENT

 

Date:_____________

 

TO:

 

The undersigned, pursuant to the provisions
set forth in the attached Warrant, hereby agrees to purchase _____________________________________ shares of Common Stock covered
by such Warrant, and makes payment herewith in full therefor at the price per share provided by this Warrant.

 

	 	VFT Special Ventures, Ltd., a
	 	Pennsylvania limited partnership 
	 	 	 	 
	 	 	 	 
	 	 	 	 
	 	By:	 	 
	 	 	Gregory Berlacher, Managing Partner	 

  

    6

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00319-of-00352.parquet"}]]